Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Breast Neoplasms 92Neoplasms 87Lung Neoplasms 55Prostatic Neoplasms 48Colorectal Neoplasms 42Carcinoma, Non-Small-Cell Lung 35Pancreatic Neoplasms 24Multiple Myeloma 24Stomach Neoplasms 21Hematologic Neoplasms 21Carcinoma, Hepatocellular 19Ovarian Neoplasms 18Melanoma 17Lymphoma 16Leukemia, Myeloid, Acute 16Esophageal Neoplasms 16Brain Neoplasms 16Urinary Bladder Neoplasms 13Liver Neoplasms 13Colonic Neoplasms 13Uterine Cervical Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasm Metastasis 12Leukemia, Lymphocytic, Chronic, B-Cell 12Leukemia 12Kidney Neoplasms 12Head and Neck Neoplasms 12Endometrial Neoplasms 12Disease 12Recurrence 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Rare Diseases × 30 days × Clear all
NCT06714370 2026-05-20

REVEAL

Ono Pharmaceutical Co., Ltd.

Completed
24 enrolled
CNSLymphoid

Brain Neoplasms, Lymphoma, Rare Diseases

NCT07247279 2026-05-13

Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia

AstraZeneca

Recruiting
450 enrolled

Myasthenia Gravis, Rare Diseases

NCT04731857 2026-05-04

EXGEFATU

University Hospital Tuebingen

Recruiting
12,000 enrolled

Genetic Risk Score, Genetic Predisposition to Disease, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡